CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 182232-182372 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"When changed to another IVIG with lower IgA content she experienced worsening of her symptoms during the 2 months that she was receiving it.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T62708","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T62708","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T342","span":{"begin":0,"end":140},"obj":"Sentence"}],"attributes":[{"subj":"T342","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1627","span":{"begin":123,"end":126},"obj":"Disease"}],"attributes":[{"id":"A1627","pred":"mondo_id","subj":"T1627","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T1627","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec9993","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93a6ec"},{"id":"CORD-19-PD-MONDO","color":"#c0ec93"}]}]}}